Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: Brian Malloy who wrote (513)	1/16/1998 12:48:00 PM
From: Brian Malloy	Read Replies (1) \| Respond to of 1972

Nice little article in BW on HIV. MRK is in the hunt and they are utilizing VICAL DNA plasmid technology as they work on a gp120 HIV vaccine. There is a decent chance that the vaccine will be out this year. A WAY TO LOCK OUT AIDS? Labs are working on treatments to foil HIV's use of cellular receptors businessweek.com Also be sure to check out the related articles. They little cartoons of the cellular receptor sites. gp120, CCR5, CD4, and CCRX4 will take the fight against HIV to a new level.